Vodis Pharmaceuticals Inc. (CSE: VP)

Vodis Pharmaceuticals Inc. (CSE:VP; OTC:VDQSF) is positioned to be among the first pharmaceutical corporations in Canada to produce and market medical marijuana under  license from Health Canada in accordance with the existing Narcotic Control Regulations  (“NCR”) and the new Marihuana for Medical Purposes Regulations (“MMPR”) that came into  effect on April 1, 2014.  Vodis filed its MMPR in August 2013 and in January 2014 received a  ‘ready to build’ letter from Health Canada. IT IS CURRENTLY AWAITING FINAL INSPECTION  FROM HEALTH CANADA.

Symbol Name Last Price Change % Change

Vodis Pharmaceuticals Inc.

Join the community! Discuss Company Information & Ideas.

Topics:
0
Replies:
0
Freshness:
Voices:
0
There are no topics posted yet.